Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis.
about
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux diseaseFamotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses.Gastroesophageal reflux disease--should we adopt a new conceptual framework?Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease.Assessment of reflux symptom severity: methodological options and their attributes.Treatment of uncomplicated reflux diseaseAn update on the available treatments for non-erosive reflux disease.Characteristics of symptomatic reflux episodes in Japanese proton pump inhibitor-refractory non-erosive reflux disease patients.Guidelines for the diagnosis and management of gastroesophageal reflux disease: an evidence-based consensus.Review of proton pump inhibitors for the initial treatment of heartburn: is there a dose ceiling effect?Acid peptic diseases: pharmacological approach to treatment.Relevance of ineffective esophageal motility and hyperactive acid sensitization in patients with gastroesophageal reflux.The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole.Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.Lansoprazole-induced improvement of esophageal submucosal injury.Reversal of the tolerance phenomenon by the intermittent administration of a histamine H2-receptor antagonist.Patient self-treatment using lansoprazole for frequent nighttime heartburn. Commentary.A comparative study of intragastric acidity during post-breakfast and pre-dinner administration of low-dose proton pump inhibitors: a randomized three-way crossover study.Lansoprazole 15 mg once daily for 14 days is effective for treatment of frequent heartburn: results of 2 randomized, placebo-controlled, double-blind studies.Management of symptoms in step-down therapy of gastroesophageal reflux disease.Development of a refractory gastro-oesophageal reflux score using an administrative claims database.Cost-effectiveness model of endoscopic biopsy for eosinophilic esophagitis in patients with refractory GERD.Efficacy of Vonoprazan for Gastroesophageal Reflux Symptoms in Patients with Proton Pump Inhibitor-resistant Non-erosive Reflux Disease.Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease
P2860
Q24236493-0E328F25-C676-4480-A37F-D25D8A0B0373Q34424848-57B50C41-2640-4B70-A89A-B8EA7F554EC0Q34515428-74BED496-A70D-43B7-AB49-25CA03AD7874Q34791820-A5AEAC5C-4157-4EB8-933B-B19226FF4274Q35026352-117DC1D8-5ED6-4D44-9011-1827A72337C5Q35745038-B15D54BB-F75E-4CF2-B059-C90963CAE14DQ36204260-6E34EEB3-7C62-4390-ACCF-C6ACD7FCA749Q36349598-83CE1547-BBC0-4B24-AC81-8EF283AC2857Q36373664-C1E43641-3EA9-420E-8CF8-B997FA1B0FC8Q37762466-9658BA4F-F2B7-4A89-938A-E6CF84BD1D05Q37864149-6E4FA062-DA1A-403D-BFA5-6F4F761F49A0Q37913063-9EDCF336-A489-48E0-A79E-96F8060986DBQ38505592-2BB4C13A-D56C-46BD-9470-D2A5909B0C41Q39377527-64FF3072-8C60-4972-93BF-38024F7C61EEQ39417568-B1684437-B47F-49F3-94DC-8A3F269FDA64Q42913767-BAD5EF1D-BCF1-426F-A66D-3D939782D4CCQ42925045-23328531-30D5-46B5-90C4-E66233051561Q43182491-3A2D8876-6666-4F5C-9569-1102CE943244Q44600156-EF1F150B-CEB2-4076-BDA1-F65FDD986C9DQ45916484-AB51E864-601A-4E0E-A3BF-51084272BDA3Q46654265-E65929F4-21D7-4342-A3C3-A44F1859B8D8Q51444133-A30E8F87-FB37-4041-A949-2381D7F26B1AQ53043334-A9870C27-B67E-421E-8137-D95E2A1AB807Q54388629-63BE81C8-0514-45D9-8E5A-6DF03D10A471Q59292004-C674BA36-8DD1-40A1-B29B-7C5F0B7758DD
P2860
Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis.
@en
Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis.
@nl
type
label
Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis.
@en
Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis.
@nl
prefLabel
Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis.
@en
Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis.
@nl
P2093
P2860
P1476
Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis.
@en
P2093
Greski-Rose PA
Huang section sign B
Richter JE
P2860
P304
P356
10.1046/J.1365-2036.1999.00558.X
P407
P577
1999-06-01T00:00:00Z